Equity
-€40,700
Debts exceed assets in financial year 2025.
EFARMZ
Lifetime
12 annual accounts with figures on one time axispeak €2.1m (2025)
€2.1m▲ 40.8%
lowest -€1.4m (2023)
-€567,233▲ €540,114
peak €2.5m (2022)
-€40,700▲ €27,487
€2.0m▼ 3.4%
peak 49.5 FTE (2023)
45.7 FTE▲ 8.0%
Board16 names since 2015all names
8 directorsAMS Equity and 7 others
Owners2 names in the annual accounts
Documentsfilings and deeds
28-05-202664 days before the deadline
2025financial year
Gross margin from €1.5m to €2.1mLoss of €567,233Staff from 42.3 FTE to 45.7 FTENew day-to-day manager 29-12Capital increase of €594,719.36 to €4,738,667.96 23-07Equity from -€68,187 to -€40,700
Key points
from the 2025 annual accountsLosses
-€4.1m in five years
Every financial year from 2021 to 2025 closed with a loss. 2023 was the heaviest.
Debts
€2.0m 102% of the balance sheet
Financial debts 43%Suppliers 33%Taxes and wages 13%Other 10%
Of this, €1.1m falls due within a year.
Staff
53 employees on 31-12-2025
In 2025, 2,490 short contracts started and 2,488 ended, on average 31 hours worked per contract. Staff averaged 46 full-time equivalents.
Filings
12 annual accounts since 2014
Three of the last ten came late. The 2019 accounts came latest: 41 days after the end of the period.
Position in the sector
-€567,233
Lower net result than 95% of companies in retail trade. Sector median €39,880 · 5,069 companies.
Checked score
50
Fair
Financially stronger than 36% of small companies in retail trade (NACE 47)
Probability in this band: 1.5% to 4.2%
Bankruptcy probability within 12 months
3.1% Moderate
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 3,698 companies (NACE 47, small).
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 1.5%
01-2025: 1.5%● unchanged vs 12-2024
02-2025: 1.5%● unchanged vs 01-2025
03-2025: 1.4%▼ -0.1 percentage points vs 02-2025lowest value
04-2025: 1.5%▲ +0.1 percentage points vs 03-2025
05-2025: 1.6%▲ +0.1 percentage points vs 04-2025
06-2025: 1.6%● unchanged vs 05-2025
07-2025: 1.9%▲ +0.3 percentage points vs 06-2025
08-2025: 5.1%▲ +3.2 percentage points vs 07-2025
09-2025: 5.1%● unchanged vs 08-2025
10-2025: 5.1%● unchanged vs 09-2025
11-2025: 5.1%● unchanged vs 10-2025
12-2025: 5.1%● unchanged vs 11-2025
01-2026: 5.1%● unchanged vs 12-2025
02-2026: 5.1%● unchanged vs 01-2026
03-2026: 5.1%● unchanged vs 02-2026
04-2026: 5.1%● unchanged vs 03-2026
05-2026: 5.2%▲ +0.1 percentage points vs 04-2026highest value
06-2026: 3.1%▼ -2.1 percentage points vs 05-2026
07-2026: 3.1%● unchanged vs 06-2026
08-2026: 3.1%● unchanged vs 07-2026
09-2026: 3.1%● unchanged vs 08-2026
10-2026: 3.1%● unchanged vs 09-2026
11-2026: 3.1%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Negative equity -€40,700
Loss of €567,233, the second in a row (financial year 2025)
Sector: Retail trade (NACE 47)
lowers risk
Liquidity: current ratio 1.08, cash €304,158
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 9% of them on solvency, 46% on liquidity, 2% on profitability and 88% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 598 companies had the same profile as EFARMZ has now. Each dot stands for 2 companies, two years later.
83.1%
were still trading
6.0%
stopped another way
9.4%
went bankrupt
Another 1.5% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of EFARMZ itself: 3.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 598 companies, not a prediction for EFARMZ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is tight, with a current ratio of 1.08 (1.08 in 2024), below the usual 1.5. Short-term debt is 56% and cash 15.6% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€40,700
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
64 days early
2024
14 days early
2023
15 days early
2022
29 days late
2021
16 days late
2020
45 days early
2019
41 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 7 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 accounts filed within 43 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Resignation: IDEACT SRL (director)
Appointment: Philippe BOYENS (director) · Gazette deed
New day-to-day manager
CABM SRL appointed, Camille Bosc resigned · Permanent representative: Thierry François · Board meeting of 22-07-2025 · Gazette deed
Capital increase of €594,719.36 to €4,738,667.96
Capital from €4,143,948.60 to €4,738,667.96, 788 new shares · Contributions: BERNARD Muriel (€48,302.08, 64 shares); BOCQUET Xavier (€7,547.20, 10 shares); BOYENS Philippe (€20,377.44, 27 shares); and 7 others · General meeting of 15-07-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0534744073
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| EFARMZ Anderlecht | €2.0m | €2.1m | -2.1% | 45.7 |
| EURO SHOP KORTRIJK Kortrijk | €2.0m | €2.3m | 26.9% | 36.3 |
| EURO SHOP TOURNAI Tournai | €1.5m | €1.8m | 39.2% | 34.5 |
| EURO SHOP MIDDELKERKE Middelkerke | €1.8m | €2.1m | 30.8% | 30.4 |
| HAPPY HOURS MARKET Molenbeek-Saint-Jean | €1.3m | €2.2m | -27.1% | 71.2 |
| MISTER GENIUS Woluwe-Saint-Lambert | €1.8m | €1.3m | 9.3% | 30.3 |
| ACE AND TATE BELGIUM Antwerp | €1.2m | €3.3m | 45.4% | 49.8 |
These companies have the same main activity as EFARMZ: other non-specialised retail sale (NACE 47120). They are comparable in size and age: total assets between €1.2m and €2m, founded between 2004 and 2018.
Official details
Source: KBO- Status
- Active since 28-05-2013Normal situation
- Activity
- Other non-specialised retail saleNACE 47120
- Joint committees
- 201Independent retail
- 119Food trade · annual accounts 2025
- Establishment unit
- 2.219.266.0671070 Anderlecht, since 03-06-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 15-04-2025
Annual accounts 2025
- ≈ €14.0mestimated
- €2.0m▼ 2.1%
- Employeeson 31-12-2025
- 53▲ 3.9%
- Filing
- Filed on 28-05-2026, 64 days before the end of the filing period
Insights on EFARMZ
EFARMZ has existed since 2013. In 2018 the gross margin rose from €128,650 to €361,863 and staff from 7.5 to 11 full-time equivalents.
In September 2022, four directors stepped down. In December 2025, the Official Gazette published the appointment of CABM SRL as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about EFARMZ
- What is the company number of EFARMZ?
- The company number of EFARMZ is 0534.744.073. The VAT number is the same number with BE in front: BE 0534.744.073.
- Where is EFARMZ based?
- The registered office is at Industrielaan 135, 1070 Anderlecht.Company details
- What does EFARMZ do?
- According to the KBO register, the main activity is other non-specialised retail sale (NACE 47120).
- What is the legal form of EFARMZ?
- EFARMZ is a private limited company (BV).
- When was EFARMZ founded?
- EFARMZ was founded on 28-05-2013.
- Is EFARMZ still active?
- Yes, EFARMZ is an active enterprise in the KBO register.
- How many employees does EFARMZ have?
- EFARMZ had an average of 45.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does EFARMZ fall under?
- In its 2025 annual accounts, EFARMZ states joint committees 201 (Independent retail) and 119 (Food trade).
- What is the turnover of EFARMZ?
- The turnover in financial year 2025 is ≈ €14.0m. This figure is estimated from the gross margin of €2.1m and 30 comparable companies (NACE 471). It probably lies between €8.7m and €17.0m.
- Is EFARMZ profitable?
- In financial year 2025, EFARMZ made a loss of €567,233.
- Where can I find the annual accounts of EFARMZ?
- EFARMZ filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of EFARMZ due?
- EFARMZ must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.